Disease | The m6A regulators | Type | Sample source | Expression change | Regulatory roles | Reference |
---|---|---|---|---|---|---|
RA | IGFBP2 | Reader | FLS | Up-regulation | Regulates the neuropeptides GHR and NPR2 to influence the interaction between FLS. | [37] |
RA | IGF2BP3 | Reader | Synovial tissues | Up-regulation | Regulates the G2/M transition and affects the polarization of M1 macrophages. | [38] |
RA | SMOC2 | - | Synovial tissues | Up-regulation | Controls MYO1C expression through ALKBH5-mediated m6A modification. | [40] |
RA | METTL3 | Writer | PBMC | Up-regulation | Attenuated LPS-induced inflammatory response in macrophages via the NF-κB signaling pathway. | [41] |
RA | METTL3 | Writer | FLS | Up-regulation | Activates the NF-κB signaling pathway. | [43] |
RA | WTAP | Writer | MH7A cells | Up-regulation | Combines with METTL3 to form the MettL3–MettL14–Wtap complex. | [52] |
RA | RIPK2 | - | MH7A cells | Up-regulation | Mediates LPS-induced p38 and IKB-α signaling. | [52] |
RA | JAK3 | - | MH7A cells | Up-regulation | Mediates and participates in the formation of cytokines. | [52] |
RA | TNFRSF10A | - | MH7A cells | Down-regulation | Activates the NF-κB pathway and promotes cell proliferation and migration. | [52] |
RA | YTHDF2 | Reader | PBMC | Down-regulation | Affects the production of autoantibodies. | [53] |
RA | FTO | Eraser | Peripheral blood | Down-regulation | Mediates methylation reversal. | [53] |
RA | ALKBH | Eraser | Peripheral blood | Down-regulation | Mediates methylation reversal. | [53] |
SLE | ALKBH5 | Eraser | Peripheral blood | Down-regulation | Affects anti-DSDNA levels | [63] |
SLE | MTEEL14 | Writer | Peripheral blood | Down-regulation | Perturbs the m6A threshold, leading to uncontrolled expression/activity of the virulence gene. | [64] |
SLE | YTHDF2 | Reader | Peripheral blood | Down-regulation | Perturbs the m6A threshold, leading to uncontrolled expression/activity of the virulence gene. | [64] |
pSS | METTL3 FTO YTHDF1 YTHDF2 | Writer Eraser Reader Reader | PBMC | Up-regulation | Targets ISG15, stimulates ISG15 expression, and activates the type I IFN signaling pathway. | [72] |
Graves’Disease | METTL3 | Writer | CD4T cells | Down-regulation | Induces SOCS mRNA m6A modification. | [79] |
MS | ALKBH5 | Eraser | T cells | Up-regulation | Controls CD4 T cell pathogenicity. | [89] |
Uveitis | FTO | Eraser | EAU mouse RPE cells | Down-regulation | Regulates the m6A level of ATF4 to affect the translation of ATF4 and the expression of inflammatory factors. | [92] |
Autoimmune hepatitis | YTHDF2 | Reader | liver | Up-regulation | Low expression of YTHDF2 can enhance the amplification, chemotaxis, and inhibition of MDSC. | [96] |